kabutan

TOCALO Co.,Ltd.(3433) Summary

3433
TSE Prime
TOCALO Co.,Ltd.
2,666
JPY
+28
(+1.06%)
Feb 4, 3:30 pm JST
17.06
USD
Feb 4, 1:30 am EST
Result
PTS
outside of trading hours
2,520
Feb 4, 9:30 pm JST
Summary Chart Historical News Financial Result
PER
19.0
PBR
2.53
Yield
2.63%
Margin Trading Ratio
3.70
Stock Price
Feb 4, 2026
Opening Feb 4, 9:00 am
2,650 JPY 17.00 USD
Previous Close Feb 3
2,638 JPY 16.97 USD
High Feb 4, 2:22 pm
2,685 JPY 17.17 USD
Low Feb 4, 9:57 am
2,629 JPY 16.85 USD
Volume
312,900
Trading Value
0.83B JPY 5.33M USD
VWAP
2661.18 JPY 17.03 USD
Minimum Trading Value
266,600 JPY 1,706 USD
Market Cap
0.16T JPY 1.05B USD
Number of Trades
1,194
Liquidity & Number of Trades
As of Feb 4, 2026
Liquidity
Slightly High
1-Year Average
648
1-Year High Nov 7, 2025
3,586
Margin Trading
Date Short Interest Long Margin Positions Ratio
Jan 30, 2026 93,500 145,100 1.55
Jan 23, 2026 69,200 138,200 2.00
Jan 16, 2026 67,000 244,700 3.65
Jan 9, 2026 64,500 203,700 3.16
Dec 26, 2025 65,500 136,700 2.09
Company Profile
TOCALO Co., Ltd. specializes in surface treatment processing, primarily for semiconductor and LCD manufacturing equipment components. The company is a leading provider of thermal spray coating services.
Sector
Metal Products
TOCALO Co., Ltd. possesses surface modification processing technologies centered on thermal spray coating. The company applies coatings of metals, ceramics, and other materials to the surfaces of various components, including semiconductor and FPD manufacturing equipment parts, industrial machinery components such as gas turbines for power generation, and facility parts like steel rolls and chemical plant components. These coatings impart various functions such as wear resistance, heat resistance, conductivity, and electrical insulation. With domestic and international subsidiaries, TOCALO also engages in PVD treatment processing and maintenance services for semiconductor manufacturing equipment parts. The company's technological portfolio includes TD treatment processing, ZAC coating, and PTA treatment.